Myron W. Shulgan - 26 Sep 2025 Form 4 Insider Report for Drugs Made In America Acquisition II Corp. (DMII)

Role
Director
Signature
/s/ Myron W. Shulgan
Issuer symbol
DMII
Transactions as of
26 Sep 2025
Transactions value $
$0
Form type
4
Filing time
02 Oct 2025, 14:51:59 UTC
Previous filing
24 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shulgan Myron W. Director C/O DRUGS MADE IN AMERICA ACQU. II CORP., 1 EAST BROWARD BOULEVARD, SUITE 700, FORT LAUDERDALE /s/ Myron W. Shulgan 02 Oct 2025 0002038614

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMII Ordinary shares Other +100K 100K 26 Sep 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of the Transaction Date, the reporting person acquired 100,000 ordinary shares from Drugs Made In America Acquisition II LLC, the Issuer's sponsor, for no consideration.